Acute heart failure. Heart failure, unspecified
Conditions
Interventions
Intervention 1: Intervention group: 1 cc/kg/h GIK solution with formula 300 g/l glucose, 80 meq/l potassium, 50 u/l insulin during 48h. Intervention 2: Control group:placebo-serum isotonic solution wi
Treatment - Drugs
Placebo
Intervention group: 1 cc/kg/h GIK solution with formula 300 g/l glucose, 80 meq/l potassium, 50 u/l insulin during 48h.
Control group:placebo-serum isotonic solution with equal volume and speed
Sponsors
Vice chancellor for research and technology, Kermanshah university of medical sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criterias: All patients presenting as acute heart failure with left ventricular ejection fraction (LVEF) 40; Diabetes mellitus; Hypoglycemia; hyperkalemia; High Hs-CRP states including Infectious and Rheumatic diseases, cancers, Tissue damages, Burns and inflammatory bowel diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hs-CRP. Timepoint: Before GIK administration, at 3rd and 5th days after GIK administration. Method of measurement: Blood test.;Nt Pro BNP. Timepoint: Before GIK administration, at 3rd and 5th days after GIK administration. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Inhospital death. Timepoint: During hospital-stay period. Method of measurement: On the basis of vital sign.;Ventricular arrhythmias. Timepoint: During hospital-stay period. Method of measurement: On the basis of cardiac monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbolfazl Enaami
Kermanshah university of medical sciences
Outcome results
None listed